This trial is studying whether a blood pressure medication can help improve symptoms in people with postural tachycardia syndrome, which mostly affects young women and causes significant disability.
1 Primary · 1 Secondary · Reporting Duration: after 30 min supine to after 15 min upright (delta VOSS), 2-3 hours after placebo or moxonidine intake [delta (delta VOSS)].
Experimental Treatment
Non-Treatment Group
48 Total Participants · 2 Treatment Groups
Primary Treatment: Moxonidine · Has Placebo Group · Phase < 1
Age 18 - 55 · Female Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Hawaii | 100.0% |
18 - 65 | 100.0% |
Met criteria | 100.0% |